Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)

China · Delayed Price · Currency is CNY

19.85

-0.48 (-2.36%)

At close: Sep 11, 2026

Market Cap	8.16B -27.7%
Revenue (ttm)	1.36B -9.4%
Net Income	42.78M -82.5%
EPS	0.10 -82.8%
Shares Out	411.25M
PE Ratio	193.05
Forward PE	44.11
Dividend	0.10 (0.49%)
Ex-Dividend Date	Jun 3, 2026

Volume	2,541,786
Open	20.20
Previous Close	20.33
Day's Range	19.82 - 20.34
52-Week Range	18.91 - 28.43
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of vaccines in China and internationally. It offers inactivated Japanese encephalitis and SPEEDA-rabies vaccines. The company also develops rabies vaccine which is in new drug approval stage; influenza vaccine which is in new drug application stage; recombinant human papillomavirus 15-valent vaccine which is in Phase II clinical stage; and 13-valent pneumococcal polysaccharide conjugate, varicella, and meningococcal ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 1,781

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688739

Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 131.79 million, a decrease of -61.56%.

Financial Statements